Replies to post #124417 on Biotech Values

[throwerw]

The results look great, so why is the stock not reacting? I've read your other posts, there's a lot to be positive about here... what has the big short interest so convinced of the opposite view?

[DewDiligence]

Correction to #msg-65857564—NVS’ operating margin on Lovenox was 69% (not 66%); MNTA’s profit share from Lovenox was $87.6M (not $83.8M) because there was a $3.7M contractual true-up of accounts in the NVS-MNTA collaboration following the first year of the product launch. (Source: MNTA’s CC)